Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEDROXYPROGESTERONE Cause Meningioma benign? 235 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 235 reports of Meningioma benign have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 2.8% of all adverse event reports for MEDROXYPROGESTERONE.

235
Reports of Meningioma benign with MEDROXYPROGESTERONE
2.8%
of all MEDROXYPROGESTERONE reports
0
Deaths
18
Hospitalizations

How Dangerous Is Meningioma benign From MEDROXYPROGESTERONE?

Of the 235 reports, 18 (7.7%) required hospitalization, and 5 (2.1%) were considered life-threatening.

Is Meningioma benign Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEDROXYPROGESTERONE. However, 235 reports have been filed with the FAERS database.

What Other Side Effects Does MEDROXYPROGESTERONE Cause?

Meningioma (1,364) Drug dose omission by device (510) Device leakage (500) Incorrect dose administered by device (410) Drug ineffective (403) Off label use (390) Syringe issue (354) Needle issue (346) Headache (288) Device occlusion (284)

What Other Drugs Cause Meningioma benign?

INTERFERON BETA-1A (21) ADALIMUMAB (20) CYPROTERONE (16) ESTRADIOL (14) DIMETHYL (10) CARBIDOPA\LEVODOPA (7) LENALIDOMIDE (6) NATALIZUMAB (6) NOMEGESTROL (6) RITUXIMAB (6)

Which MEDROXYPROGESTERONE Alternatives Have Lower Meningioma benign Risk?

MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE MEDROXYPROGESTERONE vs MEFENAMIC ACID MEDROXYPROGESTERONE vs MEFLOQUINE MEDROXYPROGESTERONE vs MEGESTROL MEDROXYPROGESTERONE vs MEGLUMINE

Related Pages

MEDROXYPROGESTERONE Full Profile All Meningioma benign Reports All Drugs Causing Meningioma benign MEDROXYPROGESTERONE Demographics